• Dihydroethidium: From Signal to Translation

  2026-09-14

  Dihydroethidium, also known as hydroethidine, can connect intracellular superoxide biology with translational decisions in oxidative stress, apoptosis, and cardiovascular disease research. This article explains how to interpret the signal, validate mechanism, and use DHE strategically in studies of doxorubicin-induced cardiac injury.

• SAR405 and the Energetic Logic of Autophagy

  2026-09-13

  A thought-leadership analysis of how SAR405, a selective Vps34 inhibitor, helps translational researchers separate energy sensing, autophagy initiation, vesicle trafficking, and lysosomal phenotypes while designing more decisive cellular and disease-model studies.

• LY2228820: p38 MAP Kinase Inhibitor Workflow

  2026-09-12

  LY2228820 combines selective p38α/β pathway control with practical readouts for cytokine release, phospho-MK2 signaling, apoptosis, and tumor-cell response. This workflow connects mechanistic kinase inhibition with anti-inflammatory research and cancer research while emphasizing formulation, controls, and troubleshooting.

• Hyperthermia–Cisplatin Drives Caspase-8 Cell Death

  2026-09-11

  A 2024 study identified a mechanistic link between hyperthermia, cisplatin, and caspase-8 accumulation, showing that K63-linked polyubiquitination and p62 interactions can amplify both apoptosis and pyroptosis. The findings position caspase-8 as a convergence point that may help explain why combined thermal and chemotherapy treatments produce stronger tumor-cell killing than either intervention alone.

• EZ Cap EGFP mRNA 5-moUTP Workflow Guide

  2026-09-11

  Use EZ Cap EGFP mRNA 5-moUTP as a quantitative reporter for delivery, translation, viability, and imaging workflows—not merely as a fluorescence reagent. Its Cap1 structure, 5-moUTP chemistry, and optimized poly(A) tail provide a stable benchmark for comparing emerging peptide coacervates and other mRNA delivery systems.

• In Vitro Cancer Drug Response: Beyond Viability

  2026-09-10

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly interchangeable readouts capture different mixtures of growth inhibition and cell killing. Its paired, time-aware framework helps researchers interpret cancer drug responses more accurately and avoid treating cytostatic effects as evidence of cytotoxicity.

• How Kinase Inhibitors Tune p38α Dephosphorylation

  2026-09-10

  The reference preprint shows that selected kinase inhibitors do more than block p38α catalytic activity: they can stabilize an activation-loop conformation that makes the phospho-threonine more accessible to the WIP1 phosphatase. This dual-action mechanism provides a structural framework for improving kinase inhibitor potency and specificity, while its relevance to cellular cytokine biology remains to be tested.

• Coumestrol: ER Antagonism Meets Ferroptosis

  2026-09-09

  Coumestrol is a phytoestrogen estrogen receptor antagonist with a distinctive concentration-dependent profile spanning ER signaling, nuclear receptor modulation, and ferroptosis research. This article explains how to interpret its RA synoviocyte findings without confusing receptor pharmacology with cell-state mechanisms.

• Mestranol Reversibly Stresses Zebrafish Microglia

  2026-09-09

  This study establishes mestranol as an inducer of a reversible lysosomal storage–like state in zebrafish microglia, defined by impaired intracellular digestion rather than increased microglial death or uptake failure. Its live in vivo model links microglial hypertrophy, lysosomal stress, and immune transcriptional suppression, creating a useful framework for studying environmental estrogen neuroimmunotoxicity.

• MVC Exploits RhoA/ROCK1/MLC2 for Viral Entry

  2026-09-08

  Ren and colleagues show that Minute Virus of Canines (MVC) VP2 directly interacts with ROCK1 and activates the RhoA/ROCK1/MLC2 axis in canine cells. The resulting actomyosin contraction disrupts tight junction organization, exposes Occludin, and promotes viral entry, identifying a host-pathway vulnerability for mechanistic antiviral research.

• Microplastics, Nanoplastics, and Pulmonary Fibrosis

  2026-09-08

  A comparative Toxicology study shows that polymer identity and particle size strongly influence the pulmonary toxicity of microplastics and nanoplastics, with polystyrene nanoplastics producing the most pronounced fibrogenic and inflammatory responses among the tested materials. The work combines mouse exposure, BEAS-2B cell experiments, and FXR-YAP1 pathway perturbation to connect particle characteristics with a plausible mechanism of pulmonary fibrosis.

• Stem Cell Screening: From Phenotype to Mechanism

  2026-09-07

  A translational framework for using DiscoveryProbe™ Stem Cell Compound Library Plus to connect stem cell phenotypes with pathway mechanism, orthogonal validation, and drug-discovery decisions across mammalian and parasite models.

• Direct Mouse Genotyping Kit: PCR Workflow

  2026-09-07

  The Direct Mouse Genotyping Kit streamlines mouse genetic screening by releasing genomic DNA from tissue for direct PCR, without conventional DNA purification. It is suited to routine endpoint genotyping and high-throughput workflows, but lysate-based products should not be assumed suitable for sequencing, quantitative PCR, or other downstream applications without separate validation.

• Epalrestat Neuroprotection via KEAP1/Nrf2 in PD

  2026-09-05

  Jia et al. report that Epalrestat, an established aldose reductase inhibitor, protects dopaminergic neurons in cellular and mouse models of Parkinson’s disease by engaging the KEAP1/Nrf2 antioxidant pathway. The study combines behavioral, molecular, and biophysical evidence, while also defining important limits for translating this preclinical mechanism into Parkinson’s disease research.

• ARCA for High-Performance mRNA Translation

  2026-09-04

  Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, enables orientation-controlled Cap 0 mRNA synthesis for efficient translation. This article explains how cap chemistry should be integrated with nanoparticle delivery, neuroinflammation assays, and mRNA therapeutics research.

8498 records 1/567 page Next 12345 下5页 Last page